Amedeo Smart

Free Medical Literature Service



Autoimmune Disorders

  Free Subscription

Articles published in
J Autoimmun
    September 2022
  1. BAKER KF, Skelton AJ, Lendrem DW, Scadeng A, et al
    Erratum to "Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study" [J. Autoimmun. 105 (December 2019) 102298].
    J Autoimmun. 2022 Sep 19:102913. doi: 10.1016/j.jaut.2022.102913.
    >> Share

  2. AZOULAY LD, Pineton de Chambrun M, Larcher R, Pene F, et al
    Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients.
    J Autoimmun. 2022;133:102908.
    >> Share

  3. SCHOLZ GA, Fux M, Christ L, Iype J, et al
    Divergent regulatory T cell responses to high-dose methylprednisolone and tocilizumab in giant cell arteritis.
    J Autoimmun. 2022;133:102909.
    >> Share

  4. ALVAREZ D, Rua C, Velasquez Berrio M, Catano JU, et al
    Extracellular vesicles released upon stimulation with antiphospholipid antibodies: An actual direct procoagulant mechanism or a new factor in the lupus anticoagulant paradox?
    J Autoimmun. 2022;133:102905.
    >> Share

  5. LI X, Zhang Y, Wang J, Li Y, et al
    zVAD alleviates experimental autoimmune hepatitis in mice by increasing the sensitivity of macrophage to TNFR1-dependent necroptosis.
    J Autoimmun. 2022;133:102904.
    >> Share

  6. SAKURABA K, Krishnamurthy A, Sun J, Zheng X, et al
    Autoantibodies targeting malondialdehyde-modifications in rheumatoid arthritis regulate osteoclasts via inducing glycolysis and lipid biosynthesis.
    J Autoimmun. 2022;133:102903.
    >> Share

  7. EFE C, Tascilar K, Gerussi A, Bolis F, et al
    SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis.
    J Autoimmun. 2022;132:102906.
    >> Share

    August 2022
  8. CHEN K, Li Y, Yang H
    Poor responses and adverse outcomes of myasthenia gravis after thymectomy: Predicting factors and immunological implications.
    J Autoimmun. 2022;132:102895.
    >> Share

  9. XIA Y, Jiang C, Yang M, Liu T, et al
    SB431542 alleviates lupus nephritis by regulating B cells and inhibiting the TLR9/TGFbeta1/PDGFB signaling.
    J Autoimmun. 2022;132:102894.
    >> Share

  10. RODRIGUEZ Y, Rojas M, Beltran S, Polo F, et al
    Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.
    J Autoimmun. 2022;132:102898.
    >> Share

  11. JIANING W, Jingyi X, Pingting Y
    Neuropsychiatric lupus erythematosus: Focusing on autoantibodies.
    J Autoimmun. 2022 Aug 24:102892. doi: 10.1016/j.jaut.2022.102892.
    >> Share

  12. JIANG Y, Cheng Y, Ma S, Li T, et al
    Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment.
    J Autoimmun. 2022 Aug 24:102887. doi: 10.1016/j.jaut.2022.102887.
    >> Share

  13. ZHANG W, Shao T, Leung PSC, Tsuneyama K, et al
    Dual B-cell targeting therapy ameliorates autoimmune cholangitis.
    J Autoimmun. 2022;132:102897.
    >> Share

  14. MYHR KA, Zinglersen AH, Hermansen MF, Jepsen MM, et al
    Left ventricular size and function in patients with systemic lupus erythematosus associate with lupus anticoagulant: An echocardiographic follow-up study.
    J Autoimmun. 2022;132:102884.
    >> Share

  15. BEVILACQUA ROLFSEN FERREIRA DA, Pereira das Neves S, Roque Oliveira SC, Marques F, et al
    Comparative effectiveness of preventive treatment with dimethyl fumarate-loaded solid lipid nanoparticles and oral dimethyl fumarate in a mouse model of multiple sclerosis.
    J Autoimmun. 2022;132:102893.
    >> Share

  16. YU C, Li P, Dang X, Zhang X, et al
    Lupus nephritis: new progress in diagnosis and treatment.
    J Autoimmun. 2022 Aug 20:102871. doi: 10.1016/j.jaut.2022.102871.
    >> Share

  17. NING W, Xu W, Cong X, Fan H, et al
    COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman.
    J Autoimmun. 2022;132:102896.
    >> Share

  18. REILY C, Rice T, Crossman DK, Rizk DV, et al
    Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy.
    J Autoimmun. 2022;132:102883.
    >> Share

  19. ROUSSELIN C, Amoura Z, Faguer S, Bataille P, et al
    Renal and vascular outcomes in patients with isolated antiphospholipid syndrome nephropathy.
    J Autoimmun. 2022;132:102889.
    >> Share

  20. XU Y, Li P, Li K, Li N, et al
    Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus.
    J Autoimmun. 2022 Aug 10:102890. doi: 10.1016/j.jaut.2022.102890.
    >> Share

  21. ARBITMAN L, Furie R, Vashistha H
    B cell-targeted therapies in systemic lupus erythematosus.
    J Autoimmun. 2022 Aug 10:102873. doi: 10.1016/j.jaut.2022.102873.
    >> Share

  22. IZAGIRRE A, Arzallus T, Garmendia M, Torrente S, et al
    Autoimmune hepatitis following COVID-19 vaccination.
    J Autoimmun. 2022;132:102874.
    >> Share

  23. SIDDIQI KZ, Zinglersen AH, Iversen KK, Rasmussen NS, et al
    A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus.
    J Autoimmun. 2022;132:102869.
    >> Share

  24. CHEN Y, Lin J, Xiao L, Zhang X, et al
    Gut microbiota in systemic lupus erythematosus: A fuse and a solution.
    J Autoimmun. 2022;132:102867.
    >> Share

    July 2022
  25. TAN Y, Yang S, Liu Q, Li Z, et al
    Pregnancy-related complications in systemic lupus erythematosus.
    J Autoimmun. 2022 Jul 21:102864. doi: 10.1016/j.jaut.2022.102864.
    >> Share

  26. LOU H, Ling GS, Cao X
    Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target.
    J Autoimmun. 2022 Jul 21:102861. doi: 10.1016/j.jaut.2022.102861.
    >> Share

  27. LI H, Boulougoura A, Endo Y, Tsokos GC, et al
    Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies.
    J Autoimmun. 2022 Jul 21:102870. doi: 10.1016/j.jaut.2022.102870.
    >> Share

  28. VIEIRA M, Comarmond C, Labreuche J, Mirouse A, et al
    COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study.
    J Autoimmun. 2022;132:102868.
    >> Share

  29. LIU Y, Yu X, Zhang W, Zhang X, et al
    Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.
    J Autoimmun. 2022 Jul 16:102863. doi: 10.1016/j.jaut.2022.102863.
    >> Share

  30. FERRI C, Gragnani L, Raimondo V, Visentini M, et al
    Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases.
    J Autoimmun. 2022;131:102866.
    >> Share

  31. NING W, Cheng D, Howe PH, Bian C, et al
    Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus.
    J Autoimmun. 2022;131:102860.
    >> Share

  32. HUANG C, Yi P, Zhu M, Zhou W, et al
    Erratum to "Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial" [J. Autoimmun. 130, June 2022, 102844].
    J Autoimmun. 2022;131:102862.
    >> Share

  33. NATARAJA C, Flynn J, Dankers W, Northcott M, et al
    GILZ regulates type I interferon release and sequesters STAT1.
    J Autoimmun. 2022;131:102858.
    >> Share

  34. IYER VS, Boddul SV, Johnsson AK, Raposo B, et al
    Modulating T-cell activation with antisense oligonucleotides targeting lymphocyte cytosolic protein 2.
    J Autoimmun. 2022;131:102857.
    >> Share

    June 2022
  35. LIU J, Zhang X, Cao X
    Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications.
    J Autoimmun. 2022 Jun 27:102856. doi: 10.1016/j.jaut.2022.102856.
    >> Share

  36. BAKASIS AD, Mavragani CP, Voulgari PV, Gerolymatou N, et al
    COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases.
    J Autoimmun. 2022;131:102846.
    >> Share

  37. HUANG C, Yi P, Zhu M, Zhou W, et al
    Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial.
    J Autoimmun. 2022 Jun 8:102844. doi: 10.1016/j.jaut.2022.102844.
    >> Share

  38. WANG C, Zhou W, Liu Y, Xu Y, et al
    Nuclear translocation of RIG-I promotes cellular apoptosis.
    J Autoimmun. 2022;130:102840.
    >> Share

    May 2022
  39. BUCCI T, Ames PR, Cammisotto V, Bartimoccia S, et al
    Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. The multicenter ATHERO-APS study.
    J Autoimmun. 2022;129:102832.
    >> Share

  40. FAN NW, Wang S, Ortiz G, Chauhan SK, et al
    Autoreactive memory Th17 cells are principally derived from T-bet(+)RORgammat(+) Th17/1 effectors.
    J Autoimmun. 2022;129:102816.
    >> Share

    April 2022
  41. MELDERIS S, Warkotsch MT, Dang J, Hagenstein J, et al
    The Amphiregulin/EGFR axis protects from lupus nephritis via downregulation of pathogenic CD4(+) T helper cell responses.
    J Autoimmun. 2022;129:102829.
    >> Share

  42. COUTANT F, Bachet R, Pin JJ, Alonzo M, et al
    Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production.
    J Autoimmun. 2022;130:102831.
    >> Share

  43. LI X, Gao L, Tong X, Chan VKY, et al
    Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong.
    J Autoimmun. 2022;130:102830.
    >> Share

    March 2022
  44. ZHAO Z, Zhu H, Li Q, Liao W, et al
    Skin CD4(+) Trm cells distinguish acute cutaneous lupus erythematosus from localized discoid lupus erythematosus/subacute cutaneous lupus erythematosus and other skin diseases.
    J Autoimmun. 2022;128:102811.
    >> Share

  45. CENTA M, Weinstein EG, Clemente JC, Faith JJ, et al
    Impaired central tolerance induces changes in the gut microbiota that exacerbate autoimmune hepatitis.
    J Autoimmun. 2022;128:102808.
    >> Share

    Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis.
    J Autoimmun. 2022;128:102813.
    >> Share

    February 2022
  47. BOSTAN H, Ucan B, Kizilgul M, Calapkulu M, et al
    Relapsed and newly diagnosed Graves' disease due to immunization against COVID-19: A case series and review of the literature.
    J Autoimmun. 2022;128:102809.
    >> Share

  48. TIAN J, Zhou H, Fang D, Yi P, et al
    The global burden of heterogeneity of lupus erythematosus interventional trials.
    J Autoimmun. 2022;128:102798.
    >> Share

  49. OHTO T, Tayeh AA, Nishikomori R, Abe H, et al
    Intracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis.
    J Autoimmun. 2022;127:102794.
    >> Share

  50. ARASE N, Tsuji H, Takamatsu H, Jin H, et al
    Corrigendum to "Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies" [J. Autoimmun. 126 (2022) 102774].
    J Autoimmun. 2022 Feb 9:102797. doi: 10.1016/j.jaut.2022.102797.
    >> Share

  51. VIEIRA M, Regnier P, Maciejewski-Duval A, Le Joncour A, et al
    Interferon signature in giant cell arteritis aortitis.
    J Autoimmun. 2022;127:102796.
    >> Share

    January 2022
  52. HANSEN CHF, Larsen CS, Zachariassen LF, Mentzel CMJ, et al
    Gluten-free diet reduces autoimmune diabetes mellitus in mice across multiple generations in a microbiota-independent manner.
    J Autoimmun. 2022;127:102795.
    >> Share

  53. PASSAM FH, Chen G, Chen VM, Qi M, et al
    Betaeta-2-glycoprotein I exerts antithrombotic function through its domain V in mice.
    J Autoimmun. 2022;126:102747.
    >> Share

    December 2021
  54. AFRASIABI A, Keane JT, Ong LTC, Alinejad-Rokny H, et al
    Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus.
    J Autoimmun. 2021;127:102781.
    >> Share

  55. ROJAS M, Ramirez-Santana C, Acosta-Ampudia Y, Monsalve DM, et al
    New insights into the taxonomy of autoimmune diseases based on polyautoimmunity.
    J Autoimmun. 2021;126:102780.
    >> Share

  56. ARASE N, Tsuji H, Takamatsu H, Jin H, et al
    Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies.
    J Autoimmun. 2021;126:102774.
    >> Share

  57. MAHROUM N, Alghory A, Kiyak Z, Alwani A, et al
    Ferritin - from iron, through inflammation and autoimmunity, to COVID-19.
    J Autoimmun. 2021;126:102778.
    >> Share

  58. RAIKER R, Pakhchanian H, DeYoung C, Gupta L, et al
    Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network.
    J Autoimmun. 2021;125:102730.
    >> Share

    November 2021
  59. AVCI E, Abasiyanik F
    Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?
    J Autoimmun. 2021;125:102745.
    >> Share

  60. FERRI C, Ursini F, Gragnani L, Raimondo V, et al
    Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.
    J Autoimmun. 2021;125:102744.
    >> Share

  61. PADOAN R, Gatto M, Ghirardello A, Tonello M, et al
    IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis.
    J Autoimmun. 2021;124:102725.
    >> Share

    October 2021
  62. TZIOUFAS AG, Bakasis AD, Goules AV, Bitzogli K, et al
    A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases.
    J Autoimmun. 2021;125:102743.
    >> Share

  63. HANSEN N, Krasiuk I, Titsch T
    Neural autoantibodies in delirium.
    J Autoimmun. 2021;125:102740.
    >> Share

  64. GARRIDO I, Lopes S, Simoes MS, Liberal R, et al
    Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence.
    J Autoimmun. 2021;125:102741.
    >> Share

  65. PATRIZIO A, Ferrari SM, Antonelli A, Fallahi P, et al
    A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination.
    J Autoimmun. 2021;125:102738.
    >> Share

    September 2021
  66. GATTO M, Saccon F, Andreoli L, Bartoloni E, et al
    Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort.
    J Autoimmun. 2021;124:102729.
    >> Share

  67. RELA M, Jothimani D, Vij M, Rajakumar A, et al
    Auto-immune hepatitis following COVID vaccination.
    J Autoimmun. 2021;123:102688.
    >> Share

  68. BOGIE JFJ, Vanmierlo T, Vanmol J, Timmermans S, et al
    Liver X receptor beta deficiency attenuates autoimmune-associated neuroinflammation in a T cell-dependent manner.
    J Autoimmun. 2021;124:102723.
    >> Share

  69. SALVIANO-SILVA A, Becker M, Augusto DG, Busch H, et al
    Genetic association and differential expression of HLAComplexGroup lncRNAs in pemphigus.
    J Autoimmun. 2021;123:102705.
    >> Share

  70. VALENTINE KM, Mullins GN, Davalos OA, Seow LW, et al
    CD8 follicular T cells localize throughout the follicle during germinal center reactions and maintain cytolytic and helper properties.
    J Autoimmun. 2021;123:102690.
    >> Share

    August 2021
  71. LEE AYS, Reed JH, Gordon TP
    Anti-Ro60 and anti-Ro52/TRIM21: Two distinct autoantibodies in systemic autoimmune diseases.
    J Autoimmun. 2021;124:102724.
    >> Share

  72. HIRSIGER JR, Tamborrini G, Harder D, Bantug GR, et al
    Chronic inflammation and extracellular matrix-specific autoimmunity following inadvertent periarticular influenza vaccination.
    J Autoimmun. 2021;124:102714.
    >> Share

  73. HEMED-SHAKED M, Cowman MK, Kim JR, Huang X, et al
    MTADV 5-MER peptide suppresses chronic inflammations as well as autoimmune pathologies and unveils a new potential target-Serum Amyloid A.
    J Autoimmun. 2021;124:102713.
    >> Share

  74. HANSEN RB, Simard JF, Faurschou M, Jacobsen S, et al
    Distinct patterns of comorbidity prior to diagnosis of incident systemic lupus erythematosus in the Danish population.
    J Autoimmun. 2021;123:102692.
    >> Share

  75. LU Q, Long H, Chow S, Hidayat S, et al
    Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
    J Autoimmun. 2021;123:102707.
    >> Share

  76. RAJENDRAN S, Quesada-Masachs E, Zilberman S, Graef M, et al
    IL-17 is expressed on beta and alpha cells of donors with type 1 and type 2 diabetes.
    J Autoimmun. 2021;123:102708.
    >> Share

  77. ZHANG P, Zhang Y, Pan M, Liu Z, et al
    Proteomic analyses of plasma-derived exosomes in immunoglobulin (Ig) G4-related disease and their potential roles in B cell differentiation and tissue damage.
    J Autoimmun. 2021;122:102650.
    >> Share

    July 2021
  78. VUILLE-LESSARD E, Montani M, Bosch J, Semmo N, et al
    Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
    J Autoimmun. 2021;123:102710.
    >> Share

  79. ZHOU S, Li Q, Zhou S, Zhao M, et al
    A novel humanized cutaneous lupus erythematosus mouse model mediated by IL-21-induced age-associated B cells.
    J Autoimmun. 2021;123:102686.
    >> Share

  80. IBANEZ-VEGA J, Vilchez C, Jimenez K, Guevara C, et al
    Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases.
    J Autoimmun. 2021;123:102702.
    >> Share

  81. BAKASIS AD, Mavragani CP, Boki KA, Tzioufas AG, et al
    COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.
    J Autoimmun. 2021;123:102687.
    >> Share

  82. GHIELMETTI M, Schaufelberger HD, Mieli-Vergani G, Cerny A, et al
    Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
    J Autoimmun. 2021;123:102706.
    >> Share

  83. GRAVER JC, Abdulahad W, van der Geest KSM, Heeringa P, et al
    Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica.
    J Autoimmun. 2021;123:102684.
    >> Share

  84. REN HM, Lukacher AE, Rahman ZSM, Olsen NJ, et al
    New developments implicating IL-21 in autoimmune disease.
    J Autoimmun. 2021;122:102689.
    >> Share

  85. MCEACHERN E, Carroll AM, Fribourg M, Schiano TD, et al
    Corrigendum to "Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis" [J. Autoimmun. 119C (2021) 102629].
    J Autoimmun. 2021;121:102665.
    >> Share

  86. MCGONAGLE D, De Marco G, Bridgewood C
    Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
    J Autoimmun. 2021;121:102662.
    >> Share

  87. DOTAN A, Shoenfeld Y
    Perspectives on vaccine induced thrombotic thrombocytopenia.
    J Autoimmun. 2021;121:102663.
    >> Share

    June 2021
  88. MONSTED MO, Falck ND, Pedersen K, Buschard K, et al
    Intestinal permeability in type 1 diabetes: An updated comprehensive overview.
    J Autoimmun. 2021;122:102674.
    >> Share

  89. LINGEL H, Meltendorf S, Billing U, Thurm C, et al
    Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.
    J Autoimmun. 2021;122:102682.
    >> Share

  90. DIANA T, Ungerer M, Wuster C, Fassbender J, et al
    A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves' disease mouse model.
    J Autoimmun. 2021;122:102666.
    >> Share

  91. GU Y, Merriman C, Guo Z, Jia X, et al
    Novel autoantibodies to the beta-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes.
    J Autoimmun. 2021;122:102677.
    >> Share

  92. RODRIGUEZ-PEREZ AI, Labandeira CM, Pedrosa MA, Valenzuela R, et al
    Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19.
    J Autoimmun. 2021;122:102683.
    >> Share

  93. KRILIS M, Qi M, Ioannou Y, Zhang JY, et al
    Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk.
    J Autoimmun. 2021;122:102675.
    >> Share

  94. KJELDSEN J, Nielsen J, Ellingsen T, Knudsen T, et al
    Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark.
    J Autoimmun. 2021;120:102632.
    >> Share

  95. DE BRUYN CARLIER T, Badloe FMS, Ring J, Gutermuth J, et al
    Autoreactive T cells and their role in atopic dermatitis.
    J Autoimmun. 2021;120:102634.
    >> Share

    May 2021
  96. NISHIMURA T, Okayasu T, Hosoi H, Kitahara T, et al
    Long-term (16-26 years) follow-up outcome of steroid therapy in refractory autoimmune sensorineural hearing loss.
    J Autoimmun. 2021;121:102664.
    >> Share

  97. TAKESHITA M, Suzuki K, Nakazawa M, Kamata H, et al
    Antigen-driven autoantibody production in lungs of interstitial lung disease with autoimmune disease.
    J Autoimmun. 2021;121:102661.
    >> Share

  98. GRAHAM JJ, Longhi MS, Heneghan MA
    T helper cell immunity in pregnancy and influence on autoimmune disease progression.
    J Autoimmun. 2021;121:102651.
    >> Share

  99. GHESQUIERE T, Ciudad M, Ramon A, Greigert H, et al
    Mucosal-associated invariant T cells in Giant Cell Arteritis.
    J Autoimmun. 2021;121:102652.
    >> Share

  100. KIM JS, Kim IH, Byun JM, Chang JH, et al
    Population-based study on the association between autoimmune disease and lymphoma: National Health Insurance Service-National Sample Cohort 2002-2015 in Korea.
    J Autoimmun. 2021;121:102647.
    >> Share

  101. YANAOKA H, Nagafuchi Y, Hanata N, Takeshima Y, et al
    Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls.
    J Autoimmun. 2021;119:102617.
    >> Share

  102. HEIKKILA N, Sormunen S, Mattila J, Harkonen T, et al
    Generation of self-reactive, shared T-cell receptor alpha chains in the human thymus.
    J Autoimmun. 2021;119:102616.
    >> Share

  103. THANOU A, Jupe E, Purushothaman M, Niewold TB, et al
    Clinical disease activity and flare in SLE: Current concepts and novel biomarkers.
    J Autoimmun. 2021;119:102615.
    >> Share

  104. HAMMINGER P, Marchetti L, Preglej T, Platzer R, et al
    Histone deacetylase 1 controls CD4(+) T cell trafficking in autoinflammatory diseases.
    J Autoimmun. 2021;119:102610.
    >> Share

    April 2021
  105. VALENTI L, Griffini S, Lamorte G, Grovetti E, et al
    Corrigendum to "Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19" [J. Autoimmun. 117C (2020) 102595].
    J Autoimmun. 2021;120:102646.
    >> Share

  106. WILHELM M, Bonam SR, Schall N, Bendorius M, et al
    Implication of a lysosomal antigen in the pathogenesis of lupus erythematosus.
    J Autoimmun. 2021;120:102633.
    >> Share

  107. WANG JY, Zhang W, Roehrl MW, Roehrl VB, et al
    An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.
    J Autoimmun. 2021;120:102644.
    >> Share

  108. VAN WIGCHEREN GF, Roelofs D, Figdor CG, Florez-Grau G, et al
    Three distinct tolerogenic CD14(+) myeloid cell types to actively manage autoimmune disease: Opportunities and challenges.
    J Autoimmun. 2021;120:102645.
    >> Share

    March 2021
  109. HALPERT G, Watad A, Tsur AM, Dotan A, et al
    Autoimmune dysautonomia in women with silicone breast implants.
    J Autoimmun. 2021;120:102631.
    >> Share

  110. MCEACHERN E, Carroll AM, Fribourg M, Schiano TD, et al
    Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis.
    J Autoimmun. 2021;119:102629.
    >> Share

  111. BENKAHLA MA, Sabouri S, Kiosses WB, Rajendran S, et al
    HLA class I hyper-expression unmasks beta cells but not alpha cells to the immune system in pre-diabetes.
    J Autoimmun. 2021;119:102628.
    >> Share

    February 2021
  112. LONGHI MS, Mieli-Vergani G, Vergani D
    Regulatory T cells in autoimmune hepatitis: Un updated overview.
    J Autoimmun. 2021;119:102619.
    >> Share

  113. PALM AE, Kleinau S
    Marginal zone B cells: From housekeeping function to autoimmunity?
    J Autoimmun. 2021;119:102627.
    >> Share

  114. KHOSRAVI-MAHARLOOEI M, Li H, Hoelzl M, Zhao G, et al
    Role of the thymus in spontaneous development of a multi-organ autoimmune disease in human immune system mice.
    J Autoimmun. 2021;119:102612.
    >> Share

  115. BERGLIN E, Mohammad AJ, Dahlqvist J, Johansson L, et al
    Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study.
    J Autoimmun. 2021;117:102579.
    >> Share

  116. GARIMELLA MG, He C, Chen G, Li QZ, et al
    The B cell response to both protein and nucleic acid antigens displayed on apoptotic cells are dependent on endosomal pattern recognition receptors.
    J Autoimmun. 2021;117:102582.
    >> Share

    January 2021
  117. MOLDOVEANU Z, Suzuki H, Reily C, Satake K, et al
    Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
    J Autoimmun. 2021;118:102593.
    >> Share

  118. PENG B, Temple BR, Yang J, Geng S, et al
    Identification of a primary antigenic target of epitope spreading in endemic pemphigus foliaceus.
    J Autoimmun. 2021;116:102561.
    >> Share

    December 2020
  119. BUITRAGO-MOLINA LE, Pietrek J, Noyan F, Schlue J, et al
    Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis.
    J Autoimmun. 2020;117:102591.
    >> Share

  120. NOVELLI L, Motta F, De Santis M, Ansari AA, et al
    The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.
    J Autoimmun. 2020;117:102592.
    >> Share

    November 2020
  121. SARMIENTO-MONROY JC, Espinosa G, Londono MC, Meira F, et al
    A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center.
    J Autoimmun. 2020;117:102580.
    >> Share

  122. ALBORZIAN DEH SHEIKH A, Gomaa S, Li X, Routledge M, et al
    A Guillain-Barre syndrome-associated SIGLEC10 rare variant impairs its recognition of gangliosides.
    J Autoimmun. 2020 Nov 19:102571. doi: 10.1016/j.jaut.2020.102571.
    >> Share

    September 2020
  123. GORABI AM, Hajighasemi S, Kiaie N, Gheibi Hayat SM, et al
    Corrigendum to "The pivotal role of CD69 in autoimmunity" [J. Autoimmun. 111C (2020) 102453].
    J Autoimmun. 2020 Sep 30:102548. doi: 10.1016/j.jaut.2020.102548.
    >> Share

  124. GOKHALE AS, Gangaplara A, Lopez-Occasio M, Thornton AM, et al
    Corrigendum to "Selective deletion of Eos (Ikzf4) in T-regulatory cells leads to loss of suppressive function and development of systemic autoimmunity" [J. Autoimmun. 105C (2019) 102300].
    J Autoimmun. 2020 Sep 24:102544. doi: 10.1016/j.jaut.2020.102544.
    >> Share

  125. CALABRESE LH, Caporali R, Blank CU, Kirk AD, et al
    Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer.
    J Autoimmun. 2020 Sep 23:102546. doi: 10.1016/j.jaut.2020.102546.
    >> Share

  126. LOMBARDI A, Concepcion E, Hou H, Arib H, et al
    Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes.
    J Autoimmun. 2020 Sep 17:102543. doi: 10.1016/j.jaut.2020.102543.
    >> Share

  127. ZHAO Y, Wei W, Liu ML
    Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications.
    J Autoimmun. 2020 Sep 4:102540. doi: 10.1016/j.jaut.2020.102540.
    >> Share

    August 2020
  128. GORABI AM, Kiaie N, Aslani S, Jamialahmadi T, et al
    Prospects for the potential of RNA interference in the treatment of autoimmune diseases: Small interfering RNAs in the spotlight.
    J Autoimmun. 2020 Aug 8:102529. doi: 10.1016/j.jaut.2020.102529.
    >> Share

    July 2020
  129. PATSOURAS M, Tsiki E, Karagianni P, Vlachoyiannopoulos PG, et al
    The role of thrombospondin-1 in the pathogenesis of antiphospholipid syndrome.
    J Autoimmun. 2020 Jul 21:102527. doi: 10.1016/j.jaut.2020.102527.
    >> Share

  130. MARZIALE A, Bettacchioli E, Picart G, Nafai S, et al
    Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases.
    J Autoimmun. 2020 Jul 18:102524. doi: 10.1016/j.jaut.2020.102524.
    >> Share

  131. LIU Y, Wang J, Luo S, Zhan Y, et al
    The roles of PPARgamma and its agonists in autoimmune diseases: A comprehensive review.
    J Autoimmun. 2020 Jul 1:102510. doi: 10.1016/j.jaut.2020.102510.
    >> Share

    June 2020
  132. THOME R, Casella G, Lotfi N, Ishikawa LWL, et al
    Primaquine elicits Foxp3(+) regulatory T cells with a superior ability to limit CNS autoimmune inflammation.
    J Autoimmun. 2020 Jun 25:102505. doi: 10.1016/j.jaut.2020.102505.
    >> Share

  133. BING SJ, Silver PB, Jittayasothorn Y, Mattapallil MJ, et al
    Autoimmunity to neuroretina in the concurrent absence of IFN-gamma and IL-17A is mediated by a GM-CSF-driven eosinophilic inflammation.
    J Autoimmun. 2020 Jun 24:102507. doi: 10.1016/j.jaut.2020.102507.
    >> Share

  134. THAM EL, Freeley SJ, Bearder S, Barros FF, et al
    VISTA deficiency protects from immune complex-mediated glomerulonephritis by inhibiting neutrophil activation.
    J Autoimmun. 2020 Jun 22:102501. doi: 10.1016/j.jaut.2020.102501.
    >> Share

  135. HU S, Liu X, Li T, Li Z, et al
    LAG3 (CD223) and autoimmunity: Emerging evidence.
    J Autoimmun. 2020 Jun 20:102504. doi: 10.1016/j.jaut.2020.102504.
    >> Share

  136. DANG J, Xu Z, Xu A, Liu Y, et al
    Human gingiva-derived mesenchymal stem cells are therapeutic in lupus nephritis through targeting of CD39(-)CD73 signaling pathway.
    J Autoimmun. 2020 Jun 18:102491. doi: 10.1016/j.jaut.2020.102491.
    >> Share

  137. EFRAIM Y, Chen FYT, Stashko C, Cheong KN, et al
    Alterations in corneal biomechanics underlie early stages of autoimmune-mediated dry eye disease.
    J Autoimmun. 2020 Jun 18:102500. doi: 10.1016/j.jaut.2020.102500.
    >> Share

  138. RODRIGUEZ Y, Novelli L, Rojas M, De Santis M, et al
    Autoinflammatory and autoimmune conditions at the crossroad of COVID-19.
    J Autoimmun. 2020 Jun 16:102506. doi: 10.1016/j.jaut.2020.102506.
    >> Share

  139. ZHOU X, Kailemia MJ, Sun Y, Shuai Z, et al
    Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis.
    J Autoimmun. 2020 Jun 13:102503. doi: 10.1016/j.jaut.2020.102503.
    >> Share

  140. ZEN M, Fuzzi E, Astorri D, Saccon F, et al
    SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
    J Autoimmun. 2020 Jun 8:102502. doi: 10.1016/j.jaut.2020.102502.
    >> Share

  141. WONG HY, Schwarz H
    CD137 / CD137 ligand signalling regulates the immune balance: A potential target for novel immunotherapy of autoimmune diseases.
    J Autoimmun. 2020 Jun 4:102499. doi: 10.1016/j.jaut.2020.102499.
    >> Share

  142. WONG ASL, Gruber DR, Richards AL, Sheldon K, et al
    Tolerization of recent thymic emigrants is required to prevent RBC-specific autoimmunity.
    J Autoimmun. 2020 Jun 2:102489. doi: 10.1016/j.jaut.2020.102489.
    >> Share

    May 2020
  143. KOMICI K, Faris P, Negri S, Rosti V, et al
    Systemic lupus erythematosus, endothelial progenitor cells and intracellular Ca(2+) signaling: A novel approach for an old disease.
    J Autoimmun. 2020 May 29:102486. doi: 10.1016/j.jaut.2020.102486.
    >> Share

  144. COLASANTI T, Sabatinelli D, Mancone C, Giorgi A, et al
    Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients.
    J Autoimmun. 2020 May 27:102470. doi: 10.1016/j.jaut.2020.102470.
    >> Share

  145. DE BONT CM, Stokman MEM, Faas P, Thurlings RM, et al
    Autoantibodies to neutrophil extracellular traps represent a potential serological biomarker in rheumatoid arthritis.
    J Autoimmun. 2020 May 22:102484. doi: 10.1016/j.jaut.2020.102484.
    >> Share

  146. YANG Y, Peng F, Wang R, Yang M, et al
    Corrigendum to "The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China" [J. Autoimmun. 109C (2020) 102434].
    J Autoimmun. 2020 May 15:102487. doi: 10.1016/j.jaut.2020.102487.
    >> Share

  147. CARL PL, Fried HM, Cohen PL
    Proteins in assemblages formed by phase separation possess properties that promote their transformation to autoantigens: Implications for autoimmunity.
    J Autoimmun. 2020 May 11:102471. doi: 10.1016/j.jaut.2020.102471.
    >> Share

    April 2020
  148. ZHANG D, Kinloch AJ, Srinath A, Shenkar R, et al
    Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu.
    J Autoimmun. 2020 Apr 30:102469. doi: 10.1016/j.jaut.2020.102469.
    >> Share

  149. LONG D, Chen Y, Wu H, Zhao M, et al
    Corrigendum to "Clinical Significance and Immunobiology of IL-21 in Autoimmunity"[J. Autoimmun. 99C (2019) p1-14].
    J Autoimmun. 2020 Apr 28:102455. doi: 10.1016/j.jaut.2020.102455.
    >> Share

  150. ZHANG X, Olsen N, Zheng SG
    The progress and prospect of regulatory T cells in autoimmune diseases.
    J Autoimmun. 2020 Apr 15:102461. doi: 10.1016/j.jaut.2020.102461.
    >> Share

  151. GORABI AM, Hajighasemi S, Kiaie N, Gheibi Hayat SM, et al
    The pivotal role of CD69 in autoimmunity.
    J Autoimmun. 2020 Apr 11:102453. doi: 10.1016/j.jaut.2020.102453.
    >> Share

  152. LEVITE M, Zelig D, Friedman A, Ilouz N, et al
    Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
    J Autoimmun. 2020 Apr 10:102462. doi: 10.1016/j.jaut.2020.102462.
    >> Share

  153. GATTO M, Radu CM, Luisetto R, Ghirardello A, et al
    Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: Insights from renal ultrastructural findings.
    J Autoimmun. 2020 Apr 4:102443. doi: 10.1016/j.jaut.2020.102443.
    >> Share

    March 2020
  154. BAE HR, Leung PSC, Hodge DL, Fenimore JM, et al
    Multi-omics: Differential expression of IFN-gamma results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases.
    J Autoimmun. 2020 Mar 24:102436. doi: 10.1016/j.jaut.2020.102436.
    >> Share

    December 2019
  155. SABOURI S, Benkahla MA, Kiosses WB, Rodriguez-Calvo T, et al
    Human herpesvirus-6 is present at higher levels in the pancreatic tissues of donors with type 1 diabetes.
    J Autoimmun. 2019 Dec 6:102378. doi: 10.1016/j.jaut.2019.102378.
    >> Share

    June 2019
  156. ZENTSOVA I, Parackova Z, Kayserova J, Palova-Jelinkova L, et al
    Monocytes contribute to DNA sensing through the TBK1 signaling pathway in type 1 diabetes patients.
    J Autoimmun. 2019 Jun 27. pii: S0896-8411(19)30191.
    >> Share

  157. TENSPOLDE M, Zimmermann K, Weber LC, Hapke M, et al
    Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
    J Autoimmun. 2019 Jun 5. pii: S0896-8411(19)30165.
    >> Share

    November 2018
    A multi-epitope DNA vaccine enables a broad engagement of diabetogenic T cells for tolerance in Type 1 diabetes.
    J Autoimmun. 2018 Nov 17. pii: S0896-8411(18)30523.
    >> Share

    October 2018
  159. ALPER CA, Larsen CE, Trautwein MR, Alford DR, et al
    A stochastic epigenetic Mendelian oligogenic disease model for type 1 diabetes.
    J Autoimmun. 2018 Oct 8. pii: S0896-8411(18)30427.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016